Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2494

1.

Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome.

Oka T, Miyagaki T.

Front Med (Lausanne). 2019 May 29;6:116. doi: 10.3389/fmed.2019.00116. eCollection 2019. Review.

2.

Genotypic characterization of HIV-1 subtype C in the central region of Nepal.

Oka T, Negi BS, Ueda S, Sasaki M, Kotaki T, Kameoka M.

AIDS Res Hum Retroviruses. 2019 Jun 1. doi: 10.1089/AID.2019.0105. [Epub ahead of print]

PMID:
31154824
3.

Phylogenetic analysis of novel posaviruses detected in feces of Japanese pigs with posaviruses and posa-like viruses of vertebrates and invertebrates.

Aoki H, Sunaga F, Ochiai H, Masuda T, Ito M, Akagami M, Naoi Y, Sano K, Katayama Y, Omatsu T, Oba M, Sakaguchi S, Furuya T, Ouchi Y, Shirai J, Mizutani T, Oka T, Nagai M.

Arch Virol. 2019 May 20. doi: 10.1007/s00705-019-04289-8. [Epub ahead of print]

PMID:
31111261
4.

Multiple Shifts of the Earliest Retrograde Atrial Activation Site Along the Tricuspid Annulus During the Fast-Slow Form of Atrioventricular Nodal Reentrant Tachycardia by Radiofrequency Modification.

Okada M, Tanaka K, Matsunaga-Lee Y, Ninomiya Y, Hirao Y, Oka T, Tanaka N, Inoue H, Iwakura K, Fujii K, Inoue K.

Int Heart J. 2019 May 30;60(3):761-767. doi: 10.1536/ihj.18-406. Epub 2019 May 17.

5.

Oncolytic herpes virus armed with vasculostatin in combination with bevacizumab abrogate glioma invasion via the CCN1 and AKT signaling pathways.

Tomita Y, Kurozumi K, Yoo JY, Fuji K, Ichikawa T, Matsumoto Y, Uneda A, Hattori Y, Shimizu T, Otani Y, Oka T, Kaur B, Date I.

Mol Cancer Ther. 2019 May 15. pii: molcanther.0799.2018. doi: 10.1158/1535-7163.MCT-18-0799. [Epub ahead of print]

PMID:
31092561
6.

Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.

Shono Y, Suga H, Kamijo H, Fujii H, Oka T, Miyagaki T, Shishido-Takahashi N, Sugaya M, Sato S.

Acta Derm Venereol. 2019 May 2. doi: 10.2340/00015555-3207. [Epub ahead of print]

7.

A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD.

Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T, Yamaguchi S, Matsui I, Hashimoto N, Matsumoto A, Shimada K, Takabatake Y, Takahashi A, Kaimori JY, Moriyama T, Yamamoto R, Horio M, Yamamoto K, Sugimoto K, Rakugi H, Isaka Y.

J Am Soc Nephrol. 2019 Jun;30(6):1073-1085. doi: 10.1681/ASN.2018111150. Epub 2019 Apr 29.

PMID:
31036759
8.

Keratinocyte Proline-Rich Protein Deficiency in Atopic Dermatitis Leads to Barrier Disruption.

Suga H, Oka T, Sugaya M, Sato Y, Ishii T, Nishida H, Ishikawa S, Fukayama M, Sato S.

J Invest Dermatol. 2019 Mar 21. pii: S0022-202X(19)31335-1. doi: 10.1016/j.jid.2019.02.030. [Epub ahead of print]

9.

Recumbent cycling with integrated volitional control electrical stimulation improves gait speed during the recovery stage in stroke patients.

Iyanaga T, Abe H, Oka T, Miura T, Iwasaki R, Takase M, Isatake M, Doi A.

J Exerc Rehabil. 2019 Feb 25;15(1):95-102. doi: 10.12965/jer.1836500.250. eCollection 2019 Feb.

10.

δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion.

Shimizu T, Ishida J, Kurozumi K, Ichikawa T, Otani Y, Oka T, Tomita Y, Hattori Y, Uneda A, Matsumoto Y, Date I.

Mol Cancer Ther. 2019 Apr;18(4):812-822. doi: 10.1158/1535-7163.MCT-18-0138. Epub 2019 Mar 14.

PMID:
30872378
11.

Effect of Extensive Ablation on Recurrence in Patients with Persistent Atrial Fibrillation Treated with Pulmonary Vein Isolation (EARNEST-PVI) trial: Design and rationale.

Dohi T, Nakatani D, Inoue K, Hikoso S, Oka T, Hayashi K, Masuda M, Furukawa Y, Kawasaki M, Egami Y, Kashiwase K, Hirata A, Watanabe T, Miyoshi M, Takeda T, Nakagawa A, Mizuno H, Minamiguchi H, Kitamura T, Suna S, Kojima T, Kida H, Bolrathanak O, Okuyama Y, Sakata Y; OCVC investigators.

J Cardiol. 2019 Aug;74(2):164-168. doi: 10.1016/j.jjcc.2019.01.010. Epub 2019 Mar 8.

PMID:
30853354
12.

Concentration of mitochondrial DNA mutations by cytoplasmic transfer from platelets to cultured mouse cells.

Ishikawa K, Kobayashi K, Yamada A, Umehara M, Oka T, Nakada K.

PLoS One. 2019 Mar 4;14(3):e0213283. doi: 10.1371/journal.pone.0213283. eCollection 2019.

13.

Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.

Shiga T, Suzuki A, Haruta S, Mori F, Ota Y, Yagi M, Oka T, Tanaka H, Murasaki S, Yamauchi T, Katoh J, Hattori H, Kikuchi N, Watanabe E, Yamada Y, Haruki S, Kogure T, Suzuki T, Uetsuka Y, Hagiwara N; HIJ-HF II Investigators.

ESC Heart Fail. 2019 Jun;6(3):475-486. doi: 10.1002/ehf2.12418. Epub 2019 Mar 3.

14.

Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer.

Yasui T, Shioyama W, Oboshi M, Oka T, Fujita M.

Intern Med. 2019 Feb 25. doi: 10.2169/internalmedicine.2415-18. [Epub ahead of print]

15.

Comparable effect of tolvaptan in heart failure patients with preserved or reduced ejection fraction.

Kiuchi S, Hisatake S, Kabuki T, Oka T, Dobashi S, Fujii T, Ikeda T.

Clin Exp Hypertens. 2019 Feb 22:1-8. doi: 10.1080/10641963.2019.1583244. [Epub ahead of print]

PMID:
30793983
16.

A case of lung adenocarcinoma complicated by pulmonary talcosis occurring in a patient employed in the confectionery industry.

Kobayashi K, Watanabe N, Oka T, Tomita H, Suzui N, Oumi Y, Hara A, Miyazaki T.

Pathol Int. 2019 Apr;69(4):229-234. doi: 10.1111/pin.12772. Epub 2019 Feb 18.

PMID:
30775827
17.

Optimization of an azetidine series as inhibitors of colony stimulating factor-1 receptor (CSF-1R) Type II to lead to the clinical candidate JTE-952.

Ikegashira K, Ikenogami T, Yamasaki T, Oka T, Hase Y, Miyagawa N, Inagaki K, Kawahara I, Koga Y, Hashimoto H.

Bioorg Med Chem Lett. 2019 Apr 1;29(7):873-877. doi: 10.1016/j.bmcl.2019.02.006. Epub 2019 Feb 7.

PMID:
30755337
18.

Comparison of the Safety and Efficacy of Automated Annotation-Guided Radiofrequency Ablation and 2nd-Generation Cryoballoon Ablation in Paroxysmal Atrial Fibrillation.

Tanaka N, Tanaka K, Ninomiya Y, Hirao Y, Oka T, Okada M, Inoue H, Nakamaru R, Takayasu K, Kitagaki R, Koyama Y, Okamura A, Iwakura K, Sakata Y, Fujii K, Inoue K.

Circ J. 2019 Feb 25;83(3):548-555. doi: 10.1253/circj.CJ-18-1035. Epub 2019 Feb 6.

19.

Chemo-enzymatic synthesis of p-nitrophenyl β-D-galactofuranosyl disaccharides from Aspergillus sp. fungal-type galactomannan.

Ota R, Okamoto Y, Vavricka CJ, Oka T, Matsunaga E, Takegawa K, Kiyota H, Izumi M.

Carbohydr Res. 2019 Feb 1;473:99-103. doi: 10.1016/j.carres.2019.01.005. Epub 2019 Jan 11.

PMID:
30658252
20.

Usefulness of Failed Electrical Cardioversion for Early Recurrence After Catheter Ablation for Atrial Fibrillation as a Predictor of Future Recurrence.

Nakamaru R, Tanaka N, Okada M, Tanaka K, Ninomiya Y, Hirao Y, Oka T, Inoue H, Koyama Y, Okamura A, Iwakura K, Rakugi H, Sakata Y, Fujii K, Inoue K.

Am J Cardiol. 2019 Mar 1;123(5):794-800. doi: 10.1016/j.amjcard.2018.11.039. Epub 2018 Dec 4.

PMID:
30558757
21.

VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases.

Matsumoto A, Matsui I, Namba T, Sakaguchi Y, Mizuno H, Shirayama Y, Shimada K, Hashimoto N, Doi Y, Yamaguchi S, Kubota K, Oka T, Mori D, Akiyama S, Hamano T, Mizui M, Takabatake Y, Kaneko T, Isaka Y.

Am J Kidney Dis. 2019 Jun;73(6):880-885. doi: 10.1053/j.ajkd.2018.10.009. Epub 2018 Dec 13.

PMID:
30554801
22.

Case of purpuric drug eruption probably induced by panitumumab.

Senda N, Miyagaki T, Oka T, Nonogaki A, Yoshizaki A, Shibata S, Sato S.

J Dermatol. 2019 Jun;46(6):e221-e222. doi: 10.1111/1346-8138.14724. Epub 2018 Dec 7. No abstract available.

PMID:
30537161
23.

Low magnesium diet aggravates phosphate-induced kidney injury.

Sakaguchi Y, Hamano T, Matsui I, Oka T, Yamaguchi S, Kubota K, Shimada K, Matsumoto A, Hashimoto N, Isaka Y.

Nephrol Dial Transplant. 2018 Dec 7. doi: 10.1093/ndt/gfy358. [Epub ahead of print]

PMID:
30535376
24.

Decreased progranulin expression in Mycosis fungoides: a possible association with the high frequency of skin infections.

Nakajima R, Miyagaki T, Kamijo H, Oka T, Shishido-Takahashi N, Suga H, Sugaya M, Sato S.

Eur J Dermatol. 2018 Dec 1;28(6):790-794. doi: 10.1684/ejd.2018.3452.

PMID:
30530405
25.

Pressure Overload Impairs Cardiac Function in Long-Chain Fatty Acid Transporter CD36-Knockout Mice.

Nakatani K, Masuda D, Kobayashi T, Sairyo M, Zhu Y, Okada T, Naito AT, Ohama T, Koseki M, Oka T, Akazawa H, Nishida M, Komuro I, Sakata Y, Yamashita S.

Int Heart J. 2019 Jan 25;60(1):159-167. doi: 10.1536/ihj.18-114. Epub 2018 Dec 5.

26.

In vitro synthesis of the human calcium transporter Letm1 within cell-sized liposomes and investigation of its lipid dependency.

Okamura K, Matsushita S, Kato Y, Watanabe H, Matsui A, Oka T, Matsuura T.

J Biosci Bioeng. 2019 May;127(5):544-548. doi: 10.1016/j.jbiosc.2018.11.003. Epub 2018 Nov 28.

PMID:
30503650
27.

Stress-induced hyperthermia and hypothermia.

Oka T.

Handb Clin Neurol. 2018;157:599-621. doi: 10.1016/B978-0-444-64074-1.00035-5. Review.

PMID:
30459027
28.

Identification of Two Mannosyltransferases Contributing to Biosynthesis of the Fungal-type Galactomannan α-Core-Mannan Structure in Aspergillus fumigatus.

Onoue T, Tanaka Y, Hagiwara D, Ekino K, Watanabe A, Ohta K, Kamei K, Shibata N, Goto M, Oka T.

Sci Rep. 2018 Nov 16;8(1):16918. doi: 10.1038/s41598-018-35059-2.

29.

Polar-Nonpolar Interfaces of Inverse Bicontinuous Cubic Phases in Phytantriol/Water System are Parallel to Triply Periodic Minimal Surfaces.

Oka T, Ohta N, Hyde S.

Langmuir. 2018 Dec 18;34(50):15462-15469. doi: 10.1021/acs.langmuir.8b03320. Epub 2018 Nov 27.

PMID:
30427193
30.
31.

Case of extranodal natural killer/T-cell lymphoma, nasal type, accompanied by Epstein-Barr virus-positive nasopharyngeal carcinoma.

Senda N, Miyagaki T, Oka T, Itoigawa A, Kikuchi K, Kobayashi T, Nakamura F, Kurokawa M, Sugaya M, Sato S.

J Dermatol. 2019 May;46(5):e161-e163. doi: 10.1111/1346-8138.14701. Epub 2018 Oct 31. No abstract available.

PMID:
30379350
32.

Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.

Senda N, Miyagaki T, Kamijo H, Nakajima R, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S.

Eur J Dermatol. 2018 Oct 1;28(5):621-627. doi: 10.1684/ejd.2018.3400.

PMID:
30378541
33.

Author Correction: Activation of endothelial β-catenin signaling induces heart failure.

Nakagawa A, Naito AT, Sumida T, Nomura S, Shibamoto M, Higo T, Okada K, Sakai T, Hashimoto A, Kuramoto Y, Oka T, Lee JK, Harada M, Ueda K, Shiojima I, Limbourg FP, Adams RH, Noda T, Sakata Y, Akazawa H, Komuro I.

Sci Rep. 2018 Oct 29;8(1):15858. doi: 10.1038/s41598-018-34062-x.

34.

Prognostic value of hypochloremia versus hyponatremia among patients with chronic kidney disease-a retrospective cohort study.

Kubota K, Sakaguchi Y, Hamano T, Oka T, Yamaguchi S, Shimada K, Matsumoto A, Hashimoto N, Mori D, Matsui I, Isaka Y.

Nephrol Dial Transplant. 2018 Oct 20. doi: 10.1093/ndt/gfy299. [Epub ahead of print]

PMID:
30346587
35.

Broadly reactive real-time reverse transcription-polymerase chain reaction assay for the detection of human sapovirus genotypes.

Oka T, Iritani N, Yamamoto SP, Mori K, Ogawa T, Tatsumi C, Shibata S, Harada S, Wu FT.

J Med Virol. 2019 Mar;91(3):370-377. doi: 10.1002/jmv.25334. Epub 2018 Nov 15.

PMID:
30320885
36.

Metabolic abnormalities in adult T-cell leukemia/lymphoma and induction of specific leukemic cell death using photodynamic therapy.

Oka T, Mizuno H, Sakata M, Fujita H, Yoshino T, Yamano Y, Utsumi K, Masujima T, Utsunomiya A.

Sci Rep. 2018 Oct 8;8(1):14979. doi: 10.1038/s41598-018-33175-7.

37.

Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma.

Suzuki H, Sugaya M, Nakajima R, Oka T, Takahashi N, Nakao M, Miyagaki T, Asano Y, Sato S.

J Dermatol. 2018 Dec;45(12):1440-1443. doi: 10.1111/1346-8138.14665. Epub 2018 Oct 5.

PMID:
30289574
38.

Multilayer graphene shows intrinsic resistance peaks in the carrier density dependence.

Hirahara T, Ebisuoka R, Oka T, Nakasuga T, Tajima S, Watanabe K, Taniguchi T, Yagi R.

Sci Rep. 2018 Sep 18;8(1):13992. doi: 10.1038/s41598-018-32214-7.

39.

Mechanism and Management of Cancer Chemotherapy-Induced Atherosclerosis.

Mukai M, Komori K, Oka T.

J Atheroscler Thromb. 2018 Oct 1;25(10):994-1002. doi: 10.5551/jat.RV17027. Epub 2018 Sep 14. Review.

40.

A 48-Year-Old Man With Multiple Pulmonary Nodular Opacities and Elevated KL-6 Level.

Nakano T, Kuwahira I, Shigemitsu H, Nakagawa T, Nagai A, Ebihara A, Oka T, Iwazaki M.

Chest. 2018 Sep;154(3):e77-e81. doi: 10.1016/j.chest.2018.03.051.

PMID:
30195375
41.

Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma.

Kamijo H, Miyagaki T, Shishido-Takahashi N, Nakajima R, Oka T, Suga H, Sugaya M, Sato S.

Blood. 2018 Nov 1;132(18):1922-1935. doi: 10.1182/blood-2018-04-845834. Epub 2018 Sep 7.

PMID:
30194255
42.

Aortic Dissection and Cardiac Dysfunction Emerged Coincidentally During the Long-Term Treatment with Angiogenesis Inhibitors for Metastatic Renal Cell Carcinoma.

Takada M, Yasui T, Oka T, Shioyama W, Kuroda T, Nakai Y, Nishimura K, Mukai M, Fujita M.

Int Heart J. 2018 Sep 26;59(5):1174-1179. doi: 10.1536/ihj.17-461. Epub 2018 Aug 29.

43.

Merkel cell polyomavirus and Langerhans cell neoplasm.

Murakami I, Wada N, Nakashima J, Iguchi M, Toi M, Hashida Y, Higuchi T, Daibata M, Matsushita M, Iwasaki T, Kuwamoto S, Horie Y, Nagata K, Hayashi K, Oka T, Yoshino T, Imamura T, Morimoto A, Imashuku S, Gogusev J, Jaubert F.

Cell Commun Signal. 2018 Aug 22;16(1):49. doi: 10.1186/s12964-018-0261-y. Review.

44.

Changes in Physicians' Intrapersonal Empathy After a Communication Skills Training in Japan.

Yamada Y, Fujimori M, Shirai Y, Ninomiya H, Oka T, Uchitomi Y.

Acad Med. 2018 Dec;93(12):1821-1826. doi: 10.1097/ACM.0000000000002426.

PMID:
30134272
45.

Association of fear of falling with acceleration-derived gait indices in older adults with knee osteoarthritis.

Oka T, Asai T, Kubo H, Fukumoto Y.

Aging Clin Exp Res. 2019 May;31(5):645-651. doi: 10.1007/s40520-018-1022-x. Epub 2018 Aug 20.

PMID:
30128664
46.

Long-Term Results of Crossover Bypass for Iliac Atherosclerotic Lesions in the Era of Endovascular Treatment: The Re-ACTION Study (Retrospective Assessment of Crossover Bypass as a Treatment for Iliac LesiONs).

Miyama N, Komai H, Nakamura T, Iwahashi M, Mukobara N, Yoshida M, Fujimura H, Sugimoto T, Asada H, Tanimura N, Azami T, Kawata M, Tsuji Y, Wakita N, Ogino H, Shindo S, Hatada A, Oka T.

Ann Vasc Dis. 2018 Jun 25;11(2):217-222. doi: 10.3400/avd.oa.18-00007.

47.

Severe Osteomalacia with Dent Disease Caused by a Novel Intronic Mutation of the CLCN5 gene.

Matsumoto A, Matsui I, Mori T, Sakaguchi Y, Mizui M, Ueda Y, Takahashi A, Doi Y, Shimada K, Yamaguchi S, Kubota K, Hashimoto N, Oka T, Takabatake Y, Sohara E, Hamano T, Uchida S, Isaka Y.

Intern Med. 2018 Dec 15;57(24):3603-3610. doi: 10.2169/internalmedicine.1272-18. Epub 2018 Aug 10.

48.

Structural insights into ubiquitin phosphorylation by PINK1.

Okatsu K, Sato Y, Yamano K, Matsuda N, Negishi L, Takahashi A, Yamagata A, Goto-Ito S, Mishima M, Ito Y, Oka T, Tanaka K, Fukai S.

Sci Rep. 2018 Jul 10;8(1):10382. doi: 10.1038/s41598-018-28656-8.

49.

Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.

Akatsuka T, Miyagaki T, Nakajima R, Kamijo H, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S.

Eur J Dermatol. 2018 Jun 1;28(3):314-319. doi: 10.1684/ejd.2018.3319.

PMID:
29952298
50.

The Japanese Immune Tolerance Induction (J-ITI) study in haemophilia patients with inhibitor: Outcomes and successful predictors of ITI treatment.

Nogami K, Taki M, Matsushita T, Ohga S, Oka T, Horikoshi Y, Amano K, Shima M.

Haemophilia. 2018 Sep;24(5):e328-e337. doi: 10.1111/hae.13531. Epub 2018 Jun 14.

PMID:
29902361

Supplemental Content

Support Center